Cargando…

Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis

BACKGROUND: Prostate-specific antigen (PSA) screening has low specificity. Assessment of methylation status in body fluids may complement PSA screening if the test has high specificity. METHOD: The purpose of this study was to conduct a meta-analysis of the sensitivity and specificity for prostate c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, T, Giovannucci, E, Welge, J, Mallick, P, Tang, W-Y, Ho, S-M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137397/ https://www.ncbi.nlm.nih.gov/pubmed/21654682 http://dx.doi.org/10.1038/bjc.2011.143

Ejemplares similares

To be screened or not to be screened? Modeling the consequences of PSA screening for the individual
por: Wever, E M, et al.
Publicado: (2012)

Feasibility of familial PSA screening: psychosocial issues and screening adherence
por: Sweetman, J, et al.
Publicado: (2006)

Screening for Prostate Cancer by Digital Rectal Examination and PSA Determination in Senegal
por: Niang, Lamine, et al.
Publicado: (2011)

Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors
por: Wever, E M, et al.
Publicado: (2013)

Lycopene, Tomato Products, and Prostate Cancer Incidence: A Review and Reassessment in the PSA Screening Era
por: Wei, Melissa Y., et al.
Publicado: (2012)

The Distribution of PSA Age-Specific Profiles in Healthy Irish Men between 20 and 70
por: Casey, R. G., et al.
Publicado: (2012)

DNA Methylation of GSTP1 in Human Prostate Tissues: Pyrosequencing Analysis
por: Yoon, Hyung-Yoon, et al.
Publicado: (2012)

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study
por: Catto, J W F, et al.
Publicado: (2011)

Image Guided Hypofractionated Radiotherapy by Helical Tomotherapy for Prostate Carcinoma: Toxicity and Impact on Nadir PSA
por: Barra, Salvina, et al.
Publicado: (2014)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
por: Hinev, Alexander I., et al.
Publicado: (2012)

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)
por: Turner, E L, et al.
Publicado: (2014)

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
por: Dearnaley, D P, et al.
Publicado: (2005)

C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk
por: Eklund, C M, et al.
Publicado: (2009)

Robotic Prostatectomy Has a Superior Outcome in Larger Prostates and PSA Density Is a Strong Predictor of Biochemical Recurrence
por: Bishara, S., et al.
Publicado: (2014)

Conjunctivitis and Total IgE in Lacrimal Fluid: Lacrytest Screening
por: Monzón, Susana, et al.
Publicado: (2009)

Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer
por: ZHANG, WEIJIE, et al.
Publicado: (2015)

GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications
por: Martignano, Filippo, et al.
Publicado: (2016)

The Effects of Lycopene on the Methylation of the GSTP1 Promoter and Global Methylation in Prostatic Cancer Cell Lines PC3 and LNCaP
por: Fu, Li-Juan, et al.
Publicado: (2014)

PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019)

The Role of (11)C-Choline-PET/CT-Guided Secondary Lymphadenectomy in Patients with PSA Failure after Radical Prostatectomy: Lessons Learned from Eight Cases
por: Martini, Thomas, et al.
Publicado: (2012)

Impact of Comorbidity, Race, and Marital Status in Men Referred for Prostate Biopsy with PSA >20 ng/mL: A Pilot Study in High-Risk Patients
por: Klaassen, Zachary, et al.
Publicado: (2014)

Tumor-associated endothelial cells display GSTP1 and RARβ2 promoter methylation in human prostate cancer
por: Grover, Amelia C, et al.
Publicado: (2006)

Association of GSTP1 and P16 promoter methylation with the risk of HBV-related hepatocellular carcinoma: a meta-analysis
por: Li, Qin, et al.
Publicado: (2018)

Early Intra-Articular Complement Activation in Ankle Fractures
por: Schmal, Hagen, et al.
Publicado: (2014)

Multiparametric MRI in the PSA Screening Era
por: George, Arvin K., et al.
Publicado: (2014)

PSA mass screening: is there enough evidence?
por: Rocco, Bernardo, et al.
Publicado: (2012)

Evaluating PSA Density as a Predictor of Biochemical Failure after Radical Prostatectomy: Results of a Prospective Study after a Median Follow-Up of 36 Months
por: Sfoungaristos, Stavros, et al.
Publicado: (2013)

Arsenic Methylation, GSTT1, GSTM1, GSTP1 Polymorphisms, and Skin Lesions
por: McCarty, Kathleen M., et al.
Publicado: (2007)

Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4–10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score
por: Fang, Dong, et al.
Publicado: (2015)

Complement C3c as a Biomarker in Heart Failure
por: Frey, A., et al.
Publicado: (2013)

Perineal Ultrasound as a Complement to POP-Q in the Assessment of Cystoceles
por: Najjari, Laila, et al.
Publicado: (2014)

Plain Radiography May Be Safely Omitted for Selected Major Trauma Patients Undergoing Whole Body CT: Database Study
por: Hudson, Sarah, et al.
Publicado: (2012)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
por: Mulugeta, Ezra, et al.
Publicado: (2011)

CLDN6 promotes chemoresistance through GSTP1 in human breast cancer
por: Yang, Minlan, et al.
Publicado: (2017)

Incidence of Histological Prostatitis and Its Correlation with PSA Density
por: Piovesan, Affonso Celso, et al.
Publicado: (2009)

High Complement Factor I Activity in the Plasma of Children with Autism Spectrum Disorders
por: Momeni, Naghi, et al.
Publicado: (2012)

Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy
por: Chen, Fei-Fei, et al.
Publicado: (2023)

Cost implications of PSA screening differ by age
por: Rao, Karthik, et al.
Publicado: (2018)

The neutrophil-to-lymphocyte ratio may indicate when to start hemodialysis
por: Lee, Tae Won, et al.
Publicado: (2022)

A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation
por: Calegari, M A, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7imtgu7rooklt07am7b9g19ha0